Skip to main content
VCbacked
Log inGet Started

Lumos Diagnostics

Carlsbad, United States

Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.

$20.0M raised
Mar 2026
Post-IPO Equity
Health CareHealth DiagnosticsMedical

Top Investors

Regal Funds ManagementBiomedical Advanced Research and Development Authority (BARDA)Planet Innovation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lumos Diagnostics

How much funding has Lumos Diagnostics raised?
Lumos Diagnostics has raised $20.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Who are Lumos Diagnostics's investors?
Lumos Diagnostics's investors include Regal Funds Management, Biomedical Advanced Research and Development Authority (BARDA), Planet Innovation.
Where is Lumos Diagnostics headquartered?
Lumos Diagnostics is headquartered in Carlsbad, United States.
What does Lumos Diagnostics do?
Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.
What stage is Lumos Diagnostics at?
Lumos Diagnostics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lumos Diagnostics — Funding & Investors." VCBacked, March 26, 2026, https://www.vcbacked.co/company/lumos-diagnostics. Accessed July 11, 2026.
APA
VCBacked. (2026). Lumos Diagnostics — Funding & Investors. Retrieved July 11, 2026, from https://www.vcbacked.co/company/lumos-diagnostics
Wikipedia (cite web)
{{cite web |title=Lumos Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/lumos-diagnostics |website=VCBacked |access-date=July 11, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Allterum Therapeutics
Houston$1.0M
Oryl Photonics
Lausanne
Rapport Therapeutics
Boston$250.0M
OncoRevive
Brunswick$119K
YLAH
Bern$589K
Novostia
Epalinges$6.6M